The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biotherapeutics Cell Line Development Market Research Report 2025

Global Biotherapeutics Cell Line Development Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1805898

No of Pages : 84

Ask Your Query

Synopsis

The global Biotherapeutics Cell Line Development market was valued at US$ 390.7 million in 2023 and is anticipated to reach US$ 591.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biotherapeutics Cell Line Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotherapeutics Cell Line Development.

Report Scope

The Biotherapeutics Cell Line Development market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biotherapeutics Cell Line Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biotherapeutics Cell Line Development companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Becton Dickinson & Company
  • Beckman Coulter
  • Boehringer Ingelheim Group
  • Catalent Inc.
  • CMC Biologics A/S
  • Lonza Group Ltd.
  • EMD Millipore
  • Partec (Sysmex Corporation)
  • ProBioGen AG
  • Selexis SA
  • Sigma-Aldrich Co. LLC.
  • Sony Biotechnology Inc.
  • Thermo Fisher Scientific Inc.

Segment by Type

  • Transfection & Selection
  • Single Cell Cloning

Segment by Application

  • In-house
  • Outsource
  • Hybrid
  • Do-It-Yourself (DIY)

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biotherapeutics Cell Line Development companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Transfection & Selection
1.2.3 Single Cell Cloning
1.3 Market by Application
1.3.1 Global Biotherapeutics Cell Line Development Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotherapeutics Cell Line Development Market Perspective (2019-2030)
2.2 Biotherapeutics Cell Line Development Growth Trends by Region
2.2.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biotherapeutics Cell Line Development Historic Market Size by Region (2019-2024)
2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Region (2025-2030)
2.3 Biotherapeutics Cell Line Development Market Dynamics
2.3.1 Biotherapeutics Cell Line Development Industry Trends
2.3.2 Biotherapeutics Cell Line Development Market Drivers
2.3.3 Biotherapeutics Cell Line Development Market Challenges
2.3.4 Biotherapeutics Cell Line Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotherapeutics Cell Line Development Players by Revenue
3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2019-2024)
3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2019-2024)
3.2 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
3.4 Global Biotherapeutics Cell Line Development Market Concentration Ratio
3.4.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2023
3.5 Biotherapeutics Cell Line Development Key Players Head office and Area Served
3.6 Key Players Biotherapeutics Cell Line Development Product Solution and Service
3.7 Date of Enter into Biotherapeutics Cell Line Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotherapeutics Cell Line Development Breakdown Data by Type
4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2019-2024)
4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2025-2030)
5 Biotherapeutics Cell Line Development Breakdown Data by Application
5.1 Global Biotherapeutics Cell Line Development Historic Market Size by Application (2019-2024)
5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biotherapeutics Cell Line Development Market Size (2019-2030)
6.2 North America Biotherapeutics Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biotherapeutics Cell Line Development Market Size by Country (2019-2024)
6.4 North America Biotherapeutics Cell Line Development Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biotherapeutics Cell Line Development Market Size (2019-2030)
7.2 Europe Biotherapeutics Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biotherapeutics Cell Line Development Market Size by Country (2019-2024)
7.4 Europe Biotherapeutics Cell Line Development Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size (2019-2030)
8.2 Asia-Pacific Biotherapeutics Cell Line Development Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2019-2024)
8.4 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biotherapeutics Cell Line Development Market Size (2019-2030)
9.2 Latin America Biotherapeutics Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biotherapeutics Cell Line Development Market Size by Country (2019-2024)
9.4 Latin America Biotherapeutics Cell Line Development Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size (2019-2030)
10.2 Middle East & Africa Biotherapeutics Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2019-2024)
10.4 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Detail
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
11.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.1.5 Becton Dickinson & Company Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
11.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Boehringer Ingelheim Group
11.3.1 Boehringer Ingelheim Group Company Detail
11.3.2 Boehringer Ingelheim Group Business Overview
11.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
11.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.3.5 Boehringer Ingelheim Group Recent Development
11.4 Catalent Inc.
11.4.1 Catalent Inc. Company Detail
11.4.2 Catalent Inc. Business Overview
11.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
11.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.4.5 Catalent Inc. Recent Development
11.5 CMC Biologics A/S
11.5.1 CMC Biologics A/S Company Detail
11.5.2 CMC Biologics A/S Business Overview
11.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
11.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.5.5 CMC Biologics A/S Recent Development
11.6 Lonza Group Ltd.
11.6.1 Lonza Group Ltd. Company Detail
11.6.2 Lonza Group Ltd. Business Overview
11.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
11.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.6.5 Lonza Group Ltd. Recent Development
11.7 EMD Millipore
11.7.1 EMD Millipore Company Detail
11.7.2 EMD Millipore Business Overview
11.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
11.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.7.5 EMD Millipore Recent Development
11.8 Partec (Sysmex Corporation)
11.8.1 Partec (Sysmex Corporation) Company Detail
11.8.2 Partec (Sysmex Corporation) Business Overview
11.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
11.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.8.5 Partec (Sysmex Corporation) Recent Development
11.9 ProBioGen AG
11.9.1 ProBioGen AG Company Detail
11.9.2 ProBioGen AG Business Overview
11.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
11.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.9.5 ProBioGen AG Recent Development
11.10 Selexis SA
11.10.1 Selexis SA Company Detail
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
11.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.10.5 Selexis SA Recent Development
11.11 Sigma-Aldrich Co. LLC.
11.11.1 Sigma-Aldrich Co. LLC. Company Detail
11.11.2 Sigma-Aldrich Co. LLC. Business Overview
11.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
11.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.11.5 Sigma-Aldrich Co. LLC. Recent Development
11.12 Sony Biotechnology Inc.
11.12.1 Sony Biotechnology Inc. Company Detail
11.12.2 Sony Biotechnology Inc. Business Overview
11.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
11.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.12.5 Sony Biotechnology Inc. Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Detail
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2019-2024)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Transfection & Selection
Table 3. Key Players of Single Cell Cloning
Table 4. Global Biotherapeutics Cell Line Development Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Biotherapeutics Cell Line Development Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biotherapeutics Cell Line Development Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Biotherapeutics Cell Line Development Market Share by Region (2019-2024)
Table 8. Global Biotherapeutics Cell Line Development Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Biotherapeutics Cell Line Development Market Share by Region (2025-2030)
Table 10. Biotherapeutics Cell Line Development Market Trends
Table 11. Biotherapeutics Cell Line Development Market Drivers
Table 12. Biotherapeutics Cell Line Development Market Challenges
Table 13. Biotherapeutics Cell Line Development Market Restraints
Table 14. Global Biotherapeutics Cell Line Development Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Biotherapeutics Cell Line Development Market Share by Players (2019-2024)
Table 16. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2023)
Table 17. Ranking of Global Top Biotherapeutics Cell Line Development Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Biotherapeutics Cell Line Development Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biotherapeutics Cell Line Development Product Solution and Service
Table 21. Date of Enter into Biotherapeutics Cell Line Development Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biotherapeutics Cell Line Development Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2019-2024)
Table 25. Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2025-2030)
Table 27. Global Biotherapeutics Cell Line Development Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2019-2024)
Table 29. Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2025-2030)
Table 31. North America Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Biotherapeutics Cell Line Development Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Biotherapeutics Cell Line Development Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Biotherapeutics Cell Line Development Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Biotherapeutics Cell Line Development Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Biotherapeutics Cell Line Development Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Biotherapeutics Cell Line Development Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Biotherapeutics Cell Line Development Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2025-2030) & (US$ Million)
Table 46. Becton Dickinson & Company Company Detail
Table 47. Becton Dickinson & Company Business Overview
Table 48. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 49. Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 50. Becton Dickinson & Company Recent Development
Table 51. Beckman Coulter Company Detail
Table 52. Beckman Coulter Business Overview
Table 53. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 54. Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 55. Beckman Coulter Recent Development
Table 56. Boehringer Ingelheim Group Company Detail
Table 57. Boehringer Ingelheim Group Business Overview
Table 58. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 59. Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 60. Boehringer Ingelheim Group Recent Development
Table 61. Catalent Inc. Company Detail
Table 62. Catalent Inc. Business Overview
Table 63. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 64. Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 65. Catalent Inc. Recent Development
Table 66. CMC Biologics A/S Company Detail
Table 67. CMC Biologics A/S Business Overview
Table 68. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 69. CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 70. CMC Biologics A/S Recent Development
Table 71. Lonza Group Ltd. Company Detail
Table 72. Lonza Group Ltd. Business Overview
Table 73. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 74. Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 75. Lonza Group Ltd. Recent Development
Table 76. EMD Millipore Company Detail
Table 77. EMD Millipore Business Overview
Table 78. EMD Millipore Biotherapeutics Cell Line Development Product
Table 79. EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 80. EMD Millipore Recent Development
Table 81. Partec (Sysmex Corporation) Company Detail
Table 82. Partec (Sysmex Corporation) Business Overview
Table 83. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product
Table 84. Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 85. Partec (Sysmex Corporation) Recent Development
Table 86. ProBioGen AG Company Detail
Table 87. ProBioGen AG Business Overview
Table 88. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 89. ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 90. ProBioGen AG Recent Development
Table 91. Selexis SA Company Detail
Table 92. Selexis SA Business Overview
Table 93. Selexis SA Biotherapeutics Cell Line Development Product
Table 94. Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 95. Selexis SA Recent Development
Table 96. Sigma-Aldrich Co. LLC. Company Detail
Table 97. Sigma-Aldrich Co. LLC. Business Overview
Table 98. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 99. Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 100. Sigma-Aldrich Co. LLC. Recent Development
Table 101. Sony Biotechnology Inc. Company Detail
Table 102. Sony Biotechnology Inc. Business Overview
Table 103. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 104. Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 105. Sony Biotechnology Inc. Recent Development
Table 106. Thermo Fisher Scientific Inc. Company Detail
Table 107. Thermo Fisher Scientific Inc. Business Overview
Table 108. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 109. Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2019-2024) & (US$ Million)
Table 110. Thermo Fisher Scientific Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotherapeutics Cell Line Development Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biotherapeutics Cell Line Development Market Share by Type: 2023 VS 2030
Figure 3. Transfection & Selection Features
Figure 4. Single Cell Cloning Features
Figure 5. Global Biotherapeutics Cell Line Development Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Biotherapeutics Cell Line Development Market Share by Application: 2023 VS 2030
Figure 7. In-house Case Studies
Figure 8. Outsource Case Studies
Figure 9. Hybrid Case Studies
Figure 10. Do-It-Yourself (DIY) Case Studies
Figure 11. Biotherapeutics Cell Line Development Report Years Considered
Figure 12. Global Biotherapeutics Cell Line Development Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Biotherapeutics Cell Line Development Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biotherapeutics Cell Line Development Market Share by Region: 2023 VS 2030
Figure 15. Global Biotherapeutics Cell Line Development Market Share by Players in 2023
Figure 16. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biotherapeutics Cell Line Development Revenue in 2023
Figure 18. North America Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Biotherapeutics Cell Line Development Market Share by Country (2019-2030)
Figure 20. United States Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Biotherapeutics Cell Line Development Market Share by Country (2019-2030)
Figure 24. Germany Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Biotherapeutics Cell Line Development Market Share by Region (2019-2030)
Figure 32. China Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Biotherapeutics Cell Line Development Market Share by Country (2019-2030)
Figure 40. Mexico Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Biotherapeutics Cell Line Development Market Share by Country (2019-2030)
Figure 44. Turkey Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Biotherapeutics Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Becton Dickinson & Company Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 47. Beckman Coulter Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 48. Boehringer Ingelheim Group Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 49. Catalent Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 50. CMC Biologics A/S Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 51. Lonza Group Ltd. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 52. EMD Millipore Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 53. Partec (Sysmex Corporation) Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 54. ProBioGen AG Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 55. Selexis SA Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 56. Sigma-Aldrich Co. LLC. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 57. Sony Biotechnology Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock